ALT & AST
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- ALT is the most liver-specific enzyme — elevated ALT almost always indicates liver involvement, whereas elevated AST can reflect muscle damage, heart disease, or hemolysis. When both are elevated together, the liver is almost certainly the source.
- Longevity-optimal ALT is below 25 U/L for men and 19 U/L for women — well below the standard upper limit of 56 U/L. Risk rises continuously above these levels, even within the 'normal' range.
- The most common cause of elevated transaminases in otherwise healthy adults is NAFLD — fatty liver disease driven by excess fructose, refined carbohydrates, alcohol, and visceral adiposity. It is largely reversible.
- ALT and AST are included in every Comprehensive Metabolic Panel (CMP) — if you've had bloodwork done in the past few years, you almost certainly have these values. Most people have never been told what they mean.
- The AST:ALT ratio carries diagnostic information. A ratio above 2:1 suggests alcohol-related liver disease. A ratio below 1:1 is typical of NAFLD. Both enzymes in isolation miss this signal.
The Liver Enzymes Almost Everyone Has — But Few Understand
ALT and AST appear on virtually every comprehensive blood panel. Most people have seen them on lab reports. Most have never been told what they mean or why they matter beyond a passing mention that values within the reference range are "fine."
They are not fine in any meaningful sense if they're in the upper half of the normal range. The clinical reference ranges for ALT and AST were established decades ago from population samples that included large numbers of people with metabolic syndrome, fatty liver disease, and early insulin resistance. A value of 45 U/L is technically "normal" — but it reflects a liver under chronic metabolic stress.
The liver is not a passive organ. It is the metabolic hub of the body: regulating blood glucose, synthesizing lipoproteins, processing hormones, clearing toxins, producing bile, and manufacturing the proteins your blood needs to clot and transport nutrients. When the liver is stressed, everything downstream is affected. Elevated ALT and AST are the body's signal that this hub is under strain.
A landmark study by Ruhl and Everhart in Gastroenterology (2009) found that serum ALT levels above 19 U/L in women and 25 U/L in men were associated with significantly increased all-cause mortality — results that held even after controlling for metabolic syndrome, alcohol use, and other confounders. These thresholds are far below the upper limits most labs use. 1
ALT vs. AST: What Each One Tells You
ALT and AST are both aminotransferases — enzymes that catalyze reactions involving amino acids. Their importance in clinical medicine comes from their location: both are found in high concentrations inside liver cells, and when those cells are damaged, the enzymes leak into the bloodstream where they can be measured.
ALT (alanine aminotransferase) is concentrated almost exclusively in liver cells, making it the more liver-specific of the two. Elevated ALT is a reliable signal of liver cell damage or inflammation, regardless of cause. It is the more sensitive early marker for metabolic liver disease.
AST (aspartate aminotransferase) is found in liver cells but also in significant concentrations in skeletal muscle, cardiac muscle, and red blood cells. This makes AST less liver-specific — an elevated AST can reflect intense exercise, a heart attack, or hemolysis rather than liver disease. When AST is elevated alongside ALT, the liver is almost certainly involved. When AST is elevated with normal ALT, non-liver causes should be considered.
The ratio between them — AST:ALT — has diagnostic value beyond either marker alone.
| Marker | Standard Range | Longevity Optimal | Notes |
|---|---|---|---|
| ALT (men) | 7–56 U/L | < 25 U/L | Most liver-specific enzyme; rises earliest in NAFLD |
| ALT (women) | 7–45 U/L | < 19 U/L | Lower threshold in women reflects different body composition |
| AST | 10–40 U/L | < 22 U/L | Less liver-specific; interpret in context of ALT |
| AST:ALT ratio | — | < 1.0 | >2:1 suggests alcohol-related disease; <1:1 suggests NAFLD |
Already have your lab results? See how your ALT, AST and other markers score on a longevity scale — in under 60 seconds.
Analyze My Biomarkers →The NAFLD Epidemic and Why It Matters for Longevity
The most common cause of elevated transaminases in otherwise healthy adults in the developed world is non-alcoholic fatty liver disease — the accumulation of fat in liver cells driven by excess caloric intake, particularly from fructose and refined carbohydrates, combined with insulin resistance and visceral adiposity.
NAFLD now affects an estimated 25–30% of the global adult population. In the United States, prevalence exceeds 30% and is rising in parallel with obesity and metabolic syndrome rates. The majority of people with NAFLD have no symptoms and will never be diagnosed unless they specifically test for it. Their first indication that something is wrong may be modestly elevated ALT on a routine blood panel — typically dismissed as "normal" because it falls within the reference range.
Why does this matter for longevity? NAFLD is not simply a liver disease. It is a systemic metabolic condition. People with NAFLD have significantly elevated risk of type 2 diabetes (the liver's impaired insulin signaling spills over into the entire metabolic system), cardiovascular disease (the liver's dysfunctional lipoprotein production drives atherogenic lipid profiles), and all-cause mortality. A 2018 meta-analysis in Gut found that NAFLD was associated with a 34% increase in all-cause mortality compared to matched controls without NAFLD. 2
The good news: early NAFLD is highly reversible. Unlike most aging-related pathologies that accumulate irreversibly, fatty liver responds rapidly and robustly to dietary and lifestyle intervention. ALT and AST tracking provides objective, quantitative feedback on liver recovery.
What Drives ALT and AST Up — and Down
Factors that raise liver enzymes
- Excess fructose — particularly from sugar-sweetened beverages and ultra-processed foods; the liver is the primary organ for fructose metabolism and converts excess fructose directly to liver fat through de novo lipogenesis
- Refined carbohydrates and excess caloric intake — drive hepatic steatosis through insulin-mediated fat accumulation in liver cells
- Alcohol — even moderate consumption raises ALT in sensitive individuals; alcohol is directly hepatotoxic and impairs mitochondrial function in liver cells
- Visceral adiposity — abdominal fat drives inflammatory signaling that promotes liver inflammation and fibrosis
- Certain medications — statins (modest, usually transient), acetaminophen (especially in excess or with alcohol), some antibiotics, antifungals, and herbal supplements including high-dose niacin, kava, and comfrey
- Intense exercise — particularly resistance training; AST rises more than ALT due to muscle breakdown
- Metabolic syndrome and insulin resistance — impair hepatic fat oxidation, promoting fat accumulation
Factors that lower liver enzymes
- Weight loss — particularly loss of visceral fat; a 7–10% reduction in body weight consistently reduces hepatic steatosis and normalizes transaminases
- Reducing fructose and refined carbohydrates — the most targeted dietary intervention for fatty liver; eliminating sugar-sweetened beverages alone can produce measurable ALT improvements within weeks
- Aerobic exercise — independently reduces liver fat content through increased hepatic fat oxidation, even without weight loss
- Eliminating or substantially reducing alcohol
- Treating underlying insulin resistance — improved insulin sensitivity reduces the lipogenic signaling that drives hepatic fat accumulation
- Coffee — multiple meta-analyses show an inverse dose-response relationship between coffee consumption and liver enzyme levels; the mechanism likely involves antioxidant and anti-inflammatory compounds in coffee
- Omega-3 fatty acids — several studies show EPA and DHA supplementation reduces hepatic fat content and lowers ALT in NAFLD patients
Interpreting ALT and AST in Context
ALT and AST are most useful when interpreted alongside other metabolic markers rather than in isolation. The liver enzymes are one piece of a broader metabolic picture.
ALT + fasting insulin + triglycerides is the most powerful combination for identifying early metabolic liver disease. Elevated ALT with elevated fasting insulin and high triglycerides — even with all values technically within normal range — is a clear signal of metabolic syndrome and likely NAFLD. This combination identifies people at high risk years before any clinical diagnosis.
ALT + albumin provides a more complete picture of liver synthetic function. Albumin is produced exclusively by the liver; falling albumin in the context of elevated ALT suggests more significant hepatic impairment beyond simple fatty infiltration.
ALT + HbA1c + triglycerides maps the full insulin resistance cluster. These four markers together — along with HDL and blood pressure — constitute the diagnostic criteria for metabolic syndrome. Any three of the five criteria being abnormal meets the threshold, but the longevity perspective is that optimization matters even when markers are technically "normal."
How to Test ALT and AST
ALT and AST are included in every Comprehensive Metabolic Panel (CMP) — one of the most commonly ordered blood tests in medicine. If you've had bloodwork in the past few years, you almost certainly already have these values. The question is whether they've been interpreted through a longevity lens.
Through the Ulta Longevity Panel: The Longevity & Healthy Aging Essential Panel includes a full CMP, covering ALT, AST, and 19 other metabolic markers alongside HbA1c, hsCRP, Vitamin D, TSH, and a lipid panel. This is the most comprehensive starting point available without a doctor's visit. $158.95 at any Quest or Labcorp location.
À la carte through Ulta Lab Tests: A standalone hepatic function panel (ALT, AST, ALP, bilirubin, albumin, total protein) is available for $25–40 without a doctor's visit. Useful for tracking liver health specifically after dietary or lifestyle intervention.
No fasting is required for ALT and AST specifically, though most comprehensive panels recommend fasting for accurate lipid and glucose values. Avoid intense exercise for 48–72 hours before testing to prevent false elevations from muscle breakdown, particularly of AST.
Sources
- Ruhl CE, Everhart JE. "Elevated Serum Alanine Aminotransferase and Gamma-Glutamyltransferase and Mortality in the United States Population." Gastroenterology, 2009. PubMed →
- Younossi Z, et al. "Global Epidemiology of Nonalcoholic Fatty Liver Disease — Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes." Hepatology, 2016. PubMed →
- Kwak MS, Kim D. "Non-alcoholic Fatty Liver Disease and Lifestyle Modifications." Intestinal Research, 2018. PubMed →
| Range Type | Value (U/L) | Notes |
|---|---|---|
| Standard Clinical Range | ALT: 7–56 U/L · AST: 10–40 U/L | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | ALT: < 25 U/L (men), < 19 U/L (women) · AST: < 22 U/L |
Associated with reduced all-cause mortality and extended healthspan.
Standard ranges were established from population averages that include people with early metabolic disease. Longevity medicine targets the lower third of the normal range. Research by Ruhl and Everhart (2009) found that all-cause mortality risk began rising at ALT above 19–25 U/L — significantly below the upper limit of standard ranges.
|
Already have your results? See what your ALT & AST and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What does it mean if my ALT is elevated but AST is normal?
Isolated ALT elevation with normal AST is the classic pattern of non-alcoholic fatty liver disease (NAFLD) and early metabolic liver stress. It typically means liver cells are under stress from excess fat accumulation, fructose metabolism, or insulin resistance — but the damage is not yet severe enough to affect AST (which rises with more significant cell death). This pattern warrants dietary and lifestyle intervention but is generally reversible. If ALT is significantly elevated (above 3x the upper limit), additional workup including imaging is appropriate.
What does an elevated AST:ALT ratio mean?
The AST:ALT ratio provides important diagnostic clues. A ratio greater than 2:1 (AST more than twice as high as ALT) strongly suggests alcohol-related liver disease — alcohol preferentially damages mitochondria in liver cells, releasing more AST than ALT. A ratio less than 1:1 (ALT higher than AST) is typical of NAFLD and metabolic liver disease. An elevated AST with normal ALT may indicate muscle damage (from intense exercise), hemolysis (red blood cell breakdown), or cardiac muscle injury — not liver disease at all. Context matters enormously when interpreting these values.
Can exercise cause elevated AST and ALT?
Yes — intense resistance training or endurance exercise can temporarily elevate both AST and ALT, primarily through muscle breakdown (rhabdomyolysis in extreme cases, mild muscle damage in normal training). AST is more affected than ALT in this context, since AST is abundant in skeletal muscle. Elevations from exercise typically normalize within 24–72 hours. If you're testing liver enzymes, avoid intense exercise for 48–72 hours before the blood draw to avoid false elevations, particularly of AST.
Is fatty liver disease reversible?
Yes — non-alcoholic fatty liver disease is substantially reversible with lifestyle intervention, particularly in early stages. Studies consistently show that 7–10% weight loss (especially loss of visceral fat) can reverse significant hepatic steatosis within 3–6 months. The most effective interventions are reducing fructose and refined carbohydrate intake, eliminating or significantly reducing alcohol, increasing aerobic exercise, and achieving a caloric deficit. Advanced fibrosis (scarring) is less reversible, but early fatty infiltration responds dramatically to lifestyle change. Regular testing of ALT every 3–6 months while intervening provides objective feedback on progress.
What else can cause elevated liver enzymes besides NAFLD?
Common causes beyond NAFLD include: alcohol consumption (even moderate drinking in sensitive individuals), medications (statins, acetaminophen, some antibiotics, certain supplements including high-dose niacin and some herbal products), viral hepatitis (B and C), autoimmune hepatitis, thyroid disorders (both hypothyroidism and hyperthyroidism), celiac disease, and hemochromatosis (iron overload). If both ALT and AST are significantly elevated (above 3x normal) and dietary/lifestyle causes have been addressed, further workup with a physician is warranted.